Advanced company searchLink opens in new window

SITRYX THERAPEUTICS LIMITED

Company number 10366466

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
07 Feb 2018 SH01 Statement of capital following an allotment of shares on 23 January 2018
  • GBP 240.01
07 Feb 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
05 Feb 2018 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
19 Jan 2018 AP03 Appointment of Miss Emma Tinsley as a secretary on 18 January 2018
09 Jan 2018 SH01 Statement of capital following an allotment of shares on 21 December 2017
  • GBP 200.01
09 Jan 2018 SH02 Sub-division of shares on 21 December 2017
05 Jan 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Sub div 21/12/2017
14 Sep 2017 CS01 Confirmation statement made on 7 September 2017 with updates
14 Feb 2017 AP01 Appointment of Ms Catherine Elizabeth Bingham as a director on 1 February 2017
14 Feb 2017 AA01 Current accounting period extended from 30 September 2017 to 31 December 2017
08 Sep 2016 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2016-09-08
  • GBP .01